🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 90400D108
- Market Cap
- Large Cap
- IPO
- 1/31/2014 · $21.00/share
Business: Ultragenyx Pharmaceutical, Inc.is a biopharmaceutical company committed to bringing to patients novel products for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.
Company Contact
- CEO
- Emil D. Kakkis
- CFO
- Howard Horn
- Headquarters
- 60 Leveroni Court, Novato, CA 94949
- Phone
- 415-483-8800
- Fax
- 415-483-8810
- Investor Relations
- Joshua Higa · 415-475-6876 · ir@ultragenyx.com